![Janet Gunzner-Toste](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Gunzner-Toste
Directeur des opérations chez
SPYRE THERAPEUTICS, INC.
Profil
Janet Gunzner-Toste is Senior Vice President-Operations at Spyre Therapeutics, Inc. since 2023.
Former roles include Chief Operating Officer at Exavir Therapeutics from 2022 to 2023, Senior Director-Program & Alliance Management at Nektar Therapeutics from 2018 to 2020, Vice President-Program Management at Eidos Therapeutics, Inc., and Senior Project Manager-Portfolio Management at Genentech, Inc. from 2003 to 2018.
Education includes a doctorate from The Scripps Research Institute, an undergraduate degree from The Reed Institute, and an MBA from Haas School of Business.
Postes actifs de Janet Gunzner-Toste
| Sociétés | Poste | Début |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur des opérations | 01/06/2023 |
Anciens postes connus de Janet Gunzner-Toste
| Sociétés | Poste | Fin |
|---|---|---|
Exavir Therapeutics
 Exavir Therapeutics Miscellaneous Commercial ServicesCommercial Services Engages in developing medicines for HIV and other viral infections | Directeur des opérations | 01/06/2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/02/2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/09/2018 |
| EIDOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Janet Gunzner-Toste
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Exavir Therapeutics
Exavir Therapeutics Miscellaneous Commercial ServicesCommercial Services Engages in developing medicines for HIV and other viral infections | Commercial Services |
